AEON Biopharma AEON
NYSE AEON
$0.20 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

AEON Biopharma (AEON) Minority Interest (2022)

AEON Biopharma (AEON) posted Minority Interest of $137.9 million for Q4 2022.

AEON Biopharma (AEON) Minority Interest (2022) Analysis & Trends

AEON Biopharma has reported Minority Interest for 1 years, with the latest figure at $137.9 million in Q4 2022.

  • Quarterly Minority Interest changed N/A year-over-year to $137.9 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $137.9 million (changed N/A YoY) and the FY2022 annual result came in at $137.9 million, changed N/A from the prior year.
  • Minority Interest was little changed at $137.9 million in Q4 2022 per AEON's latest filing.
  • Over five years, Minority Interest peaked at $137.9 million in Q4 2022 and troughed at $137.9 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 AEON Biopharma 10.06 Mn 6.62 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 137.95 Mn